Making trade policies more accountable and human rights-consistent: A NGO perspective of using human rights instruments in the case of access to medicines

Economic Globalisation and Human Rights

Volumn , Issue , 2007, Pages 170-209

  Ovett, Davinia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881892146     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511493935.009     Document Type: Chapter

References (45)

1. Trade - Human Rights - Equitable Economy, ‘Denmark and Italy, Trade-related intellectual property rights, access to medicines and human rights’, Geneva, October 2004, http://www.3dthree.org/pdf_3D/3DCESCR-DenmarkItalyBriefOct04en.pdf (accessed: 1 October 2005)
2. Trade - Human Rights - Equitable Economy, ‘Access to Affordable Drugs: Victims of HIV/AIDS Should Not Suffer From Trade Rules, UN Committee Warns Botswana that US-SACU FTA Should Not Undermine Access to HIV/AIDS Treatment’, Geneva, 4 October 2004, http://www.3dthree.org/pdf_3DZBotswanaCOPressRelease_en.pdf (accessed: 1 October 2005)
3. Trade - Human Rights - Equitable Economy, ‘Trade-related intellectual property rights, trade in services and the fulfilment of children’s rights - Botswana’, Geneva, September 2004, http://www.3dthree.org/pdf_3D/3DCRCBotswanaSept04en.pdf (accessed: 1 October 2005)
4. Trade - Human Rights - Equitable Economy, ‘Access to Affordable Drugs: A Right no FTA can ignore. UN Committee Warns Ecuador that US-Andean FTA Must Not Undermine Human Rights’, Press Release, 18 May 2004, http://www.3dthree.org/pdf_3D/EcuadorPress18May04_en.pdf (accessed: 1 October 2005)
5. Trade - Human Rights - Equitable Economy, ‘Trade-related intellectual property rights, access to medicines and the right to health - Ecuador’, April 2004, http://www.3dthree.org/pdf_3D/3DCESCREcuadorBrief04en.pdf (accessed: 1 October 2005)
6. Abbot, F.M., ‘The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a Dark Corner at the WTO’, JIEL 5 (2002), 469-505
7. Baker, B. K., ‘Process and Issues for Improving Access to Medicines, Willingness and Ability to Utilise TRIPS Flexibilities in Non-Producing Countries’, DFID Health Systems Resource Centre, August 2004, http://www.dfidhealthrc.org/shared/publications/Issues_papers/ATM/Baker.pdf (accessed: 1 October 2005)
8. Centro de Derechos Económicos y Sociales, ‘Medicamentos Genéricos y Derechos Humanos’, DESC Para la Acción, Boletín 1, September 2004, http://www.cdes.org.ec/biblioteca/biblioteca.html (accessed: 1 October 2005)
9. Centro de Derechos Económicos y Sociales, ‘Ecuador: Jefe de equipo negociador TLC contrario al Decreto Ejecutivo. Genéricos son esenciales “para el derechos a la salud” y están por sobre intereses privados y específicos’, Press Release, 16 August 2004, http://www.cdes.org.ec/biblioteca/biblioteca.html (accessed: 1 October 2005)
10. Centro Pro Juarez, ‘Unfulfilled Obligations, Human Rights and Free Trade Agreements in the Americas’, 9 July 2004, http://www.centroprodh.org.mx/english/publications/publications/2004/alca_english_web.pdf (accessed: 1 October 2005)
11. Centro Pro Juarez, ‘Los Derechos Humanos en los Procesos de Integración Económica en las Americas’, Statement for the CIDH, October 2004 http://www.choike.org/documentos/tlc_cidh_ddhh.pdf (accessed: 1 October 2005)
12. Correa, C.M., ‘Implementation of the WTO General Council Decision on Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health’, WHO Essential Drugs and Medicines Policy, April 2004, http://www.who.int/medicines/areas/policy/WTO_DOHA_DecisionPara6final.pdf (accessed: 1 October 2005)
13. Correa, C.M., ‘Implications of the Doha Declaration on TRIPS and Public Health’, WHO, Health Economics and Drugs EDM Series No.12, June 2002
14. Correa, C.M., ‘Implementing the TRIPS Agreement: General Context and Implications for Developing Countries’, Third World Network (1998)
15. Cortes, K. ‘Brazil Deputies Suspend Patents on AIDS Drugs’, Bloomberg, 1 June 2005
16. Cullet, P., ‘Patents and medicines: the relationship between TRIPS and the human right to health’, International Affairs 79 1 (2003) 139-160
17. Déclaration de Berne and MSF Switzerland, ‘Open letter to the trade and foreign ministers of EFTA’s states’, Lausanne, 2 November 2004, http://www.evb.ch/en/p25009520.html (accessed: 1 October 2005)
18. Déclaration de Berne and Liechtensteinische Gesellschaft für Umweltschutz, ‘Southern African Countries have taken a firm stand against EFTA demands on Intellectual Property Rights in Free Trade Agreement’, Press Release, Lausanne, 4 March 2005. http://www.evb.ch/en/p25009521.html (accessed: 1 October 2005)
19. Déclaration de Berne and Liechtensteinische Gesellschaft für Umweltschutz (LGU), ‘Request for an urgent appeal to stop EFTA Member States (Switzerland, Norway, Iceland and Liechtenstein), from imposing TRIPSplus rules in free trade agreements (FTAs) with Thailand’, Lausanne, 20 June 2005, http://www.evb.ch/en/p25009762.html (accessed: 1 October 2005)
20. Elliot, R., TRIPS and Rights: International Human Rights Law, Access to Medicines and the Interpretation of the WTO Agreement on Trade-Related Aspects of Intellectual Property (Toronto: Canadian HIV/AIDS Legal Network, November 2001), http://www.aidslaw.ca/Maincontent/issues/cts/briefs/TRIPS-human-rights-briefPDF.pdf (accessed: 1 October 2005)
21. European Commission, Proposal for a Regulation of the European Parliament and of the Council on Compulsory Licensing of Patents Relating to the Manufacture of Pharmaceutical Products for Export to Countries with Public Health Problems, COM (04) 737, 29 October 2004
22. European Commission, Strategy for the Enforcement of Intellectual Property Rights in Third Countries, 2005/C 129/03, 23 June 2004
23. European Commission, Proposal for a Regulation of the European Parliament and of the Council on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems, COM2994, 29 October 2004
24. Fink, C. and Reichenmiller, P., ‘Tightening TRIPS: The Intellectual Property Provisions of Recent US Free Trade Agreements’, World Bank Trade Note 20 (7 February 2005)
25. FTA Watch, ‘FTA Watch and allies sent an appeal to the Special Rapporteur, urging for monitoring of the Thai government’s violation of right to access to medicines of Thai people through FTAs Thailand-the US’, Press Release, 15 June 2005, http://www.ftawatch.org/autopage1/show_page.php?t=22&s_id=3& d_id=3 (accessed: 1 October 2005)
26. FTA Watch, ‘Request for an urgent appeal on the impact of strict intellectual property rules in free trade agreement (FTA) on access to affordable medicines in Thailand’, June 2005, http://www.ftawatch.org/autopage1/show_page.php?t=22&s_id=3&d_id=3 (accessed: 1 October 2005)
27. Hunt, P., ‘The UN Special Rapporteur on the Right to Health: Key Objectives, Themes, and Interventions’, Health and Human Rights: An International Journal 7 (2003) 1, 1-27.
28. International Centre for Trade and Sustainable Development, ‘Human Rights Commission Calls on States to Use TRIPS Flexibilities’, Bridges’ Weekly Trade News Digest 9 (13) (20 April 2005)
29. Lamy, P., ‘Speech of the European Commissioner for Trade at the International Conference on the 10th Anniversary of the WTO TRIPS Agreement’, 23 June 2004
30. Leckie, S., ‘The Committee on Economic, Social and Cultural Rights: Catalyst for Change in a System Needing Reform’, in Alston, P. and Crawford, J., The Future of UN Human Rights Treaty Monitoring (Cambridge: Cambridge University Press, 2000), pp. 129-144
31. Lopez Linares, R., ‘La Salud Pública en riesgo, Los medicamentos en el TLC’, Observatorio del Derecho a la Salud 10 (2005) http://www.aislac.org/pdf/otras_publicaciones/4_saludenriesgo_tlc.pdf (accessed: 1 October 2005)
32. Mathiason, N., ‘Drugs: Round One to Africa,’ The Observer, 22 April 2001, http://observer.guardian.co.uk/business/story/0,6903,476408,00.html (accessed: 1 October 2005)
33. Médecins sans Frontières, Prognosis: ‘Short-Term Relief, Long-Term Pain. The Future of Generic Medicines Made In India’, Briefing Note, 21 April 2005, http://www.msf.fr/documents/sida/2005-04-21-IndiaPatentsAnalysis.pdf (accessed: 1 October 2005)
34. Médecins sans Frontières, ‘Access to Medicines at Risk Across the Globe: What to Watch Out For in Free Trade Agreements with the United States’, Briefing Note, May 2004, http://www.accessmed-msf.org/documents/ftabriefingenglish.pdf (accessed: 1 October 2005)
35. Musungu, S. and Oh, C., The Use of Flexibilities in TRIPS by Developing Countries: Can They Promote Access to Medicines?, WHO Commission on Intellectual Property Rights, Innovation and Public Health, Study 4C, August 2005, http://www.who.int/intellectualproperty/studies/TRIPSFLEXI.pdf (accessed: 1 October 2005)
36. Oxfam International, Undermining access to medicines: Comparison of five US FTA’s, A technical note, Oxfam Briefing Note, June 2004, http://www.oxfam.org.uk/what_we_do/issues/health/undermining_access_ftas.htm (accessed: 1 October 2005).
37. REBRIP, Declaration of Civil Society regarding the Brazilian Negotiations for Voluntary Licence for Aids Drugs, Rio de Janeiro, 5 May 2005, http://lists.essential.org/pipermail/ip-health/2005-May/007908.html (accessed: 1 October 2005)
38. Reinhard, J., ‘Deprive Doha of all Substance, How through Bilateral Agreements EFTA States impose to Developing Countries Intellectual Property Rules on Medicines that are beyond the WTO Obligations and that restrict Access to Medicines’, Lausanne: Déclaration de Berne, November 2004, http://www.evb.ch/cm_data/depriveDoha.pdf (accessed: 1 October 2005)
39. Roffe, P., ‘Bilateral agreements and a TRIPS-plus world: the Chile-USA Free Trade Agreement’, UNCTAD-ICTSD TRIPS Issues Papers, Ottowa: QIAP, 2004
40. Sell, S. K., Private Power, Public Law: The Globalisation of Intellectual Property Rights (Cambridge: Cambridge University Press, 2003)
41. UK Commission on Intellectual Property Rights, Integrating Intellectual Property Rights and Development Policy, February 2003, 3rd edition, http://www.iprcommission.org/papers/pdfs/final_report/Ch2final.pdf (accessed: 1 October 2005)
42. Vandoren, P. and Van Eeckhaute, J. C., ‘The WTO Decision on Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Making it Work’, Journal of World Intellectual Property 6 (2003) 6, 779-793
43. Watal J., Intellectual Property Rules in the WTO and Developing Countries (The Hague: Kluwer Academic Publishers, 2001)
44. Yamin, A. E., ‘Not Just a Tragedy: Access to Medications as a Right Under International Law’, Boston University International Law Journal 21 (2003), 101-145
45. Yerkey, G. G. and Pruzin, D., ‘United States Drops WTO Case Against Brazil Over HIV/AIDS Patent Law,’ The Bureau of National Affairs (26 June 2001)